With me on the line this morning are David Cordani, The Cigna Group's Chairman and Chief Executive Officer; Brian Evanko, President and Chief Operating Officer; and Ann Dennison, Chief Financial ...

clinical safety and long-term lifestyle changes,” Cigna COO Brian Evanko said on the call. Evanko sought to differentiate Cigna’s approach to GLP-1s from tactics taken by other PBMs to help ...

I'm Ralph Giacobbe, Senior Vice President of Investor Relations. With me on the line this morning are David Cordani, The Cigna Group's Chairman and Chief Executive Officer; Brian Evanko, President and ...

Cigna is doubling down on its efforts to manage ... The new offering will be available next month, Chief Financial Officer Brian Evanko said on the insurer's earnings call on Friday.

With me on the line this morning are David Cordani, Cigna Corporation's Chairman and Chief Executive Officer, Brian Evanko, President and Chief Operating Officer, and Ann Dennison, Chief Financial ...

With me on the line this morning are David Cordani, the Cigna Group's Chairman and Chief Executive Officer; Brian Evanko, President and Chief Operating Officer; and Ann Dennison, Chief Financial ...

Brian Evanko, Cigna's chief operating officer, noted that Cigna had increased stop-loss prices for 2025 because of the surge in claims. "We've been able to execute this while preserving our ...

affordability, clinical safety and long-term lifestyle changes,” Cigna COO Brian Evanko said on the call.

“These treatments have been called once in a generation, and we all know they're changing lives and changing health care,” Cigna (NYSE:CI) CEO Brian Evanko said after his company posted better ...

Cigna's first-quarter financial results got ... sectors in the industry,” President and Chief Operating Officer Brian Evanko told financial analysts on the company’s first-quarter earnings ...

Brian Evanko, Cigna’s president and chief operating officer, noted that the U.S. market in GLP-1 medications, used to treat diabetes and weight loss management, will reach $100 billion by 2030.